Stocks and Finance

PDL BioPharma

PDL BioPharma 11/2/2011

14:46 : PDL BioPharma Inc (PDLI) Passes Through 10% Yield Mark - Looking at the universe of stocks we cover at Dividend Channel, in trading on Wednesday, shares of PDL BioPharma Inc (NASD: PDLI) were yielding above the 10% mark based on its quarterly dividend (annualized to $0.60), with the stock ...
Source : forbes-com

PDL BioPharma 9/8/2011

08:11 : PDL BioPharma (PDLI) says it expects Q3 revenue of $83M (-3% Y/Y), guidanc - PDL BioPharma (PDLI) says it expects Q3 revenue of $83M (-3% Y/Y), guidance below analyst estimates of $87.7M. The firm expects reduced royalty revenue from Avastin to only be partially offset by an increase in royalties from Herceptin, ...
Source : seekingalpha-com

PDL BioPharma 6/9/2011

06:57 : PDL BioPharma (PDLI) revises its Q2 revenue guidance to ~$122M, down from - PDL BioPharma (PDLI) revises its Q2 revenue guidance to ~$122M, down from prior guidance of $128M, due to a mathematical error made on the earlier guidance. Shares -1.5%. (PR) Post your comment!
Source : seekingalpha-com
actualidad PDL BioPharma -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts